Original document(64 pages)  中文版
    The present invention relates to novel compounds selected from 2-(3substitutedaryl)amino-4-aryl-thiazoles that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
Application Number
申请号		 200580008189 Application Date
申请日		 2005.01.28
Title 名称 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
Publication Number
公开号		 1934107 Publication Date
公开日		 2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D417/04;C07D417/14;A61K31/4439
Applicant(s) Name
申请人		 Science AB
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 chengwei
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.